Literature DB >> 22503372

Immune activation, viral gene product expression and neurotoxicity in the HIV-1 transgenic rat.

Walter Royal1, Li Zhang, Ming Guo, Odell Jones, Harry Davis, Joseph L Bryant.   

Abstract

The HIV-1 transgenic (TG) rat has been shown to be a useful model of nervous system disease that occurs in human HIV-1 infection. Studies were, therefore, performed to examine characteristics of the immune response in the periphery and brain of the animals and expression of factors in the nervous system that might be associated with neurotoxicity. Activated splenocytes from wild-type (WT) and TG rats were stimulated with either CD3/CD28 or with lipopolysaccharide (LPS) and examined for proliferative responses and for proinflammatory cytokine (IFN-γ, TNF-α and IL-1β) secretion. Brain tissue lysates from the rats were also examined for proinflammatory cytokine levels and tissue sections were stained by immunofluorescence for class II MHC+, ED1+ or Iba1+ (for macrophages and microglial cells), and for GFAP+ (for astrocytes) cells and for co-labeling of these cells for TNF-α. Co-labeling was also performed to identify cells expressing HIV-1 gp160, tat, nef and vif. Finally, on Western blots brain tissue lysates were examined for phosphorylation of Erk1/2, p38, JNK-SAPK and Erk5. TG rat splenocyte proliferative responses were higher than for WT with CD3/CD28-stimulation but lower than WT with LPS stimulation. CD3/CD28-stimulated TG rat splenocytes also secreted higher levels of IFN-γ, TNF-α and IL-1β whereas LPS-stimulated TG rat splenocytes secreted higher levels of only TNF-α than cultures from WT rats. Levels of all three cytokines were higher in brain lysates from TG rats than for WT rats. On immunofluorescence staining of corresponding sections of brain, TG rats contained increased numbers of class II MHC+ and ED1+ cells, and there was also increased co-labeling or these cells as well as astrocytes for TNF-α. Iba1+ cells showed positive staining for all of the HIV proteins whereas astrocytes showed significant positive staining for only nef and vif. Phosphorylation of Erk1/2, p38 and JNK/SAPK was detected for both TG and WT rat tissues with higher levels of phosphorylation forms of these proteins detected in the TG rat brain. Phosphorylation of Erk5, a marker that is associated with specifically neuronal repair, was detected only in TG rat brain. These studies suggest that activated nervous system mononuclear phagocytes and astrocytes expressing HIV-1 gene products in specific patterns are associated with neurodegeneration in the HIV-1 TG rat.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22503372      PMCID: PMC3351529          DOI: 10.1016/j.jneuroim.2012.03.015

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  41 in total

Review 1.  Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus.

Authors:  Susanne Kramer-Hämmerle; Ina Rothenaigner; Horst Wolff; Jeanne E Bell; Ruth Brack-Werner
Journal:  Virus Res       Date:  2005-08       Impact factor: 3.303

2.  Human immunodeficiency virus type 1 pathobiology studied in humanized BALB/c-Rag2-/-gammac-/- mice.

Authors:  Santhi Gorantla; Hannah Sneller; Lisa Walters; John G Sharp; Samuel J Pirruccello; John T West; Charles Wood; Stephen Dewhurst; Howard E Gendelman; Larisa Poluektova
Journal:  J Virol       Date:  2006-12-20       Impact factor: 5.103

3.  Neuropathologic and neuroinflammatory activities of HIV-1-infected human astrocytes in murine brain.

Authors:  Huanyu Dou; Justin Morehead; Jennifer Bradley; Santhi Gorantla; Brent Ellison; Jeff Kingsley; Lynette M Smith; Wei Chao; Galina Bentsman; David J Volsky; Howard E Gendelman
Journal:  Glia       Date:  2006-08-01       Impact factor: 7.452

4.  Methamphetamine-induced behavioral sensitization is enhanced in the HIV-1 transgenic rat.

Authors:  Xiangqian Liu; Linda Chang; Michael Vigorito; Marley Kass; He Li; Sulie L Chang
Journal:  J Neuroimmune Pharmacol       Date:  2009-05-15       Impact factor: 4.147

5.  A vitamin A deficient diet enhances proinflammatory cytokine, Mu opioid receptor, and HIV-1 expression in the HIV-1 transgenic rat.

Authors:  Walter Royal; Huiyun Wang; Odell Jones; Hieu Tran; Joseph L Bryant
Journal:  J Neuroimmunol       Date:  2007-02-07       Impact factor: 3.478

Review 6.  CNS inflammation and macrophage/microglial biology associated with HIV-1 infection.

Authors:  Anjana Yadav; Ronald G Collman
Journal:  J Neuroimmune Pharmacol       Date:  2009-09-19       Impact factor: 4.147

Review 7.  The signaling pathway leading to extracellular signal-regulated kinase 5 (ERK5) activation via G-proteins and ERK5-dependent neurotrophic effects.

Authors:  Yutaro Obara; Norimichi Nakahata
Journal:  Mol Pharmacol       Date:  2009-10-26       Impact factor: 4.436

Review 8.  HIV infection of the central nervous system: clinical features and neuropathogenesis.

Authors:  Lysa Boissé; M John Gill; Christopher Power
Journal:  Neurol Clin       Date:  2008-08       Impact factor: 3.806

9.  The HIV-1 transgenic rat as a model for HIV-1 infected individuals on HAART.

Authors:  Jinsong Peng; Michael Vigorito; Xiangqian Liu; Dunjing Zhou; Xiongwen Wu; Sulie L Chang
Journal:  J Neuroimmunol       Date:  2009-11-13       Impact factor: 3.478

10.  Morphine causes rapid increases in glial activation and neuronal injury in the striatum of inducible HIV-1 Tat transgenic mice.

Authors:  Annadora J Bruce-Keller; Jadwiga Turchan-Cholewo; Eric J Smart; Theresa Geurin; Ashok Chauhan; Rollie Reid; Ruqiang Xu; Avindra Nath; Pamela E Knapp; Kurt F Hauser
Journal:  Glia       Date:  2008-10       Impact factor: 7.452

View more
  51 in total

1.  Anti-inflammatory Function of Phyllostachys Edulis Extract in the Hippocampus of HIV-1 Transgenic Rats.

Authors:  Xiaosha Pang; Jun Panee
Journal:  J HIV AIDS       Date:  2016-05-11

2.  Temporal processsing demands in the HIV-1 transgenic rat: Amodal gating and implications for diagnostics.

Authors:  Kristen A McLaurin; Rosemarie M Booze; Charles F Mactutus
Journal:  Int J Dev Neurosci       Date:  2016-12-28       Impact factor: 2.457

3.  Exposure to HIV-1 Tat in brain impairs sensorimotor gating and activates microglia in limbic and extralimbic brain regions of male mice.

Authors:  Jason J Paris; Harminder D Singh; Amanda N Carey; Jay P McLaughlin
Journal:  Behav Brain Res       Date:  2015-05-22       Impact factor: 3.332

4.  HIV-1 Tat Primes and Activates Microglial NLRP3 Inflammasome-Mediated Neuroinflammation.

Authors:  Ernest T Chivero; Ming-Lei Guo; Palsamy Periyasamy; Ke Liao; Shannon E Callen; Shilpa Buch
Journal:  J Neurosci       Date:  2017-03-07       Impact factor: 6.167

5.  Modeling deficits in attention, inhibition, and flexibility in HAND.

Authors:  Landhing M Moran; Rosemarie M Booze; Charles F Mactutus
Journal:  J Neuroimmune Pharmacol       Date:  2014-04-25       Impact factor: 4.147

6.  Combined chronic blockade of hyper-active L-type calcium channels and NMDA receptors ameliorates HIV-1 associated hyper-excitability of mPFC pyramidal neurons.

Authors:  Christina E Khodr; Lihua Chen; Sonya Dave; Lena Al-Harthi; Xiu-Ti Hu
Journal:  Neurobiol Dis       Date:  2016-06-17       Impact factor: 5.996

7.  Increased Sensitivity to Cocaine Self-Administration in HIV-1 Transgenic Rats is Associated with Changes in Striatal Dopamine Transporter Binding.

Authors:  Scot McIntosh; Tammy Sexton; Lindsey P Pattison; Steven R Childers; Scott E Hemby
Journal:  J Neuroimmune Pharmacol       Date:  2015-03-10       Impact factor: 4.147

8.  Diagnostic and prognostic biomarkers for HAND.

Authors:  Kristen A McLaurin; Rosemarie M Booze; Charles F Mactutus
Journal:  J Neurovirol       Date:  2019-01-03       Impact factor: 2.643

9.  Inflammation and oxidative stress induced by cigarette smoke in Lewis rat brains.

Authors:  A Khanna; M Guo; M Mehra; W Royal
Journal:  J Neuroimmunol       Date:  2012-09-30       Impact factor: 3.478

10.  A Gap in Time: Extending our Knowledge of Temporal Processing Deficits in the HIV-1 Transgenic Rat.

Authors:  Kristen A McLaurin; Landhing M Moran; Hailong Li; Rosemarie M Booze; Charles F Mactutus
Journal:  J Neuroimmune Pharmacol       Date:  2016-10-03       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.